Table 2.
Comparisons of clinical complications, treatment, and hospital outcomes between the two study groups.
| Survivors (n = 30) |
Non-Survivors (n = 12) |
p Value | |
|---|---|---|---|
| Complications | |||
| Bacteremia | 2 (7) | 1 (33) | 0.026 |
| Treatments | |||
| IMV | 27 (90) | 12 (100) | 0.256 |
| Corticosteroid use | 16 (53) | 8 (67) | 0.430 |
| Vasopressors use | 10 (33) | 9 (75) | 0.014 |
| Outcomes | |||
| ICU days | 18 [9–22] | 26 [16–38] | 0.062 |
| Hospitalization days | 28 [16–55] | 30 [18–48] | 0.944 |
| IMV days | 16 [11–31] | 18 [12–38] | 0.503 |
HAP, hospital acquired pneumonia; IMV, invasive mechanical ventilation; NIPPV, noninvasive positive pressure ventilators; ICU, intensive care unit. Continuous data were expressed as median with interquartile range [IQR] and were compared by Mann–Whitney U test. Categorical variables were expressed as number of patients (%) and were compared by chi-square test. A p value of <0.05 was considered statistically significant.